Article

Periconceptional folic acid-containing multivitamin supplementation for the prevention of neural tube defects and cardiovascular malformations.

Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary.
Annals of Nutrition and Metabolism (Impact Factor: 1.66). 01/2011; 59(1):38-40. DOI: 10.1159/000332125
Source: PubMed

ABSTRACT The prevention of neural tube defects with periconceptional folic acid or folic acid-containing multivitamin supplementation is accepted by the scientific community; here the possible prevention of cardiovascular malformations is discussed. The aim of this presentation is to show the main findings of trials and studies that resulted in the prevention of neural tube defects and particularly cardiovascular malformations by folic acid-containing multivitamins or folic acid supplementation in order to stimulate the incorporation of folic acid-containing multivitamins or folic acid in the prevention of cardiovascular malformations.

0 Bookmarks
 · 
68 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: To identify behavior theory-based strategies to improve compliance with daily multiple micronutrient supplementation (MMS) among rural Ghanaian women. Components of a multi-theoretical framework were investigated in focus groups of reproductive-aged women in 6 communities. Participants were generally unaware of MMS' purpose. Perceived benefits included better health and stimulated appetite, which some believe escalates food purchases and financial constraints. Cost, forgetfulness, and unsustainability were also perceived barriers. Facilitators for compliance incorporated initial visual reminders and daily announcements with reinforcement using the 'keeper' system. Application of a tailored health behavioral model can effectively guide the design, implementation and evaluation of community-based MMS interventions.
    American journal of health behavior 11/2013; 37(6):831-40. · 1.31 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Assess racial/ethnic and sex differences in treatment of vitamin D deficiency with high dose ergocalciferol ('vitamin D2') or other forms of vitamin D in a northeastern U.S. ambulatory clinic of an academic urban medical center.
    American Journal of Pharmacy Benefits 01/2014; 6(1):e1-e8.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To assess racial/ethnic and sex differences in treat-ment of vitamin D defi ciency in a northeastern US ambulatory clinic of an academic urban medical center. Study Design: Cross-sectional observational review of electronic medication prescribing records of patients with 25-hydroxyvitamin D (25OHD) defi ciency from 2004 to 2008. Methods: Using multivariable logistic regression with adjustment for patients' demographics and Elixhauser comorbidity score, we examined the association of sex and race/ethnicity with a pre-scription for at least 1 dose of vitamin D. Results: Among 2140 patients without renal disease who were tested for 25OHD defi ciency (25OHD <20 ng/mL), 66.2% received no vitamin D prescription for vitamin D defi ciency. Blacks and Hispanics received vitamin D prescriptions more often than whites: 37.8% and 38.4% versus 30.9%, respectively (P = .003). The vitamin D prescription rate for women was 26.3% versus 7.5% for men (P = .003). In a fully adjusted model, no difference in prescription likelihood for blacks and whites (odds ratio [OR] = 1.18, 95% confi dence interval [CI], 0.88-1.58; P = .29) or Hispanics and whites was noted (OR = 1.01, 95% CI, 0.70-1.45; P = .73). Similarly, the fully adjusted model showed no difference in prescription likelihood for women and men (OR = 1.23, 95% CI, 0.93-1.63; P = .12). Conclusions: Among primary care patients with vitamin D defi -ciency, the rate of vitamin D supplementation was low. Interven-tions to correct the high prevalence of vitamin D defi ciency should address the markedly low rate of vitamin D prescribing when 25OHD levels are measured. Am J Pharm Benefi ts. 2014;6(1):e1-e8 Original Research V itamin D defi ciency, defi ned as a 25-hydroxyvitamin D (25OHD) level less than 20 ng/mL, is widespread due to low dietary intake, low supplement use, and sun avoidance. 1,2 Vitamin D defi ciency is associated with a myriad of costly diseases including fractures, 3-7 sepsis, 8-13
    American Journal of Pharmacy Benefits 01/2014;

Preview

Download
0 Downloads
Available from